ஏட்ரியல் குறு நடுக்கம் ஆரோக்கியம் ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Herald News
FALL RIVER – Southcoast Health is enrolling patients in a new clinical trial to evaluate the use of a new heart ablation technology designed to treat atrial fibrillation.
The community health system’s Cardiovascular Care Center at Charlton Memorial Hospital was the first in the world to perform the procedure during the pivotal phase of the research trial that precedes FDA approval, said Southcoast Clinical Research Coordinator Debra Benevides.
The investigational device exemption pivotal trial is called Pulsed AF and utilizes the Medtronic PulseSelect Pulsed Field Ablation System, a breakthrough technology that uses pulsed electric fields to treat atrial fibrillation by interrupting irregular heart rhythms. ....

Rhode Island , United States , Peter Cohn , Ramin Davoudi , Arnoldas Giedrimas , Cardiovascular Care Center At Charlton Memorial Hospital , Electrophysiology At Southcoast Health , Southcoast Clinical Research Coordinator Debra Benevides , Southcoast Cardiovascular Care Center , Southcoast Health , Boston Scientific , Southcoast Atrial Fibrillation Wellness Program , Heart Hospital , Cardiovascular Care Center , Charlton Memorial Hospital , Southcoast Clinical Research Coordinator Debra , Southcoast Cardiovascular Care , Pulseselect System , Nitesh Sood , Medical Director , Atrial Fibrillation Wellness Program , Pulseselect Pulsed Field Ablation , New England , ரோட் தீவு , ஒன்றுபட்டது மாநிலங்களில் , பீட்டர் கோன் ,